Back
Dyne Therapeutics Stock Price Chart

The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
43
DYN
Dyne Therapeutics
Last Price:
$11.70
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio-
The current trend is moderately bullish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Dyne Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.83 | Sell |
20-day SMA: | 11.59 | Buy |
50-day SMA: | 10.61 | Buy |
200-day SMA: | 23.47 | Sell |
8-day EMA: | 11.79 | Sell |
20-day EMA: | 11.29 | Buy |
50-day EMA: | 9.14 | Buy |
200-day EMA: | 3.89 | Buy |
Dyne Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.77 | Buy |
Relative Strength Index (14 RSI): | 53.5 | Buy |
Chaikin Money Flow: | 992764 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.52 - 12.2) | Buy |
Bollinger Bands (100): | (9.12 - 17.22) | Sell |
Dyne Therapeutics Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Dyne Therapeutics Stock
Is Dyne Therapeutics Stock a Buy?
-
Dyne Therapeutics share price is 11.69 while DYN 8-day simple moving average is 11.83, which is a Sell signal.
-
The stock price of DYN is 11.69 while Dyne Therapeutics 20-day SMA is 11.59, which makes it a Buy.
-
Dyne Therapeutics 50-day simple moving average is 10.61 while DYN share price is 11.69, making it a Buy technically.
-
DYN stock price is 11.69 and Dyne Therapeutics 200-day simple moving average is 23.47, creating a Sell signal.
DYN Technical Analysis vs Fundamental Analysis
Sell
43
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy or a Sell?
-
Dyne Therapeutics stock is rated a SellThe current Dyne Therapeutics [DYN] share price is $11.69. The Score for DYN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Dyne Therapeutics Stock Info
Market Cap:
1.3B
Price in USD:
11.69
Share Volume:
1.5M
Dyne Therapeutics 52-Week Range
52-Week High:
47.45
52-Week Low:
6.36
Sell
43
Dyne Therapeutics (DYN)
is a Sell
Dyne Therapeutics Share Price Forecast
-
What is the Dyne Therapeutics stock price today?The Dyne Therapeutics stock price is 11.69 USD today.
-
Will DYN stock go up or go down?Dyne Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Dyne Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dyne Therapeutics is overvalued.
Is Dyne Therapeutics Stock a Buy?
-
Dyne Therapeutics share price is 11.69 while DYN 8-day exponential moving average is 11.79, which is a Sell signal.
-
The stock price of DYN is 11.69 while Dyne Therapeutics 20-day EMA is 11.29, which makes it a Buy.
-
Dyne Therapeutics 50-day exponential moving average is 9.14 while DYN share price is 11.69, making it a Buy technically.
-
DYN stock price is 11.69 and Dyne Therapeutics 200-day simple moving average is 3.89, creating a Buy signal.
Fundamental Analysis of Dyne Therapeutics
Is Dyne Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.44 per share, and an increase next year of $0.14 per share.
Technical Analysis of Dyne Therapeutics
Should I short Dyne Therapeutics stock?
-
DYN Moving Average Covergence Divergence (MACD) indicator is 0.77, suggesting Dyne Therapeutics is a Buy
-
Dyne Therapeutics Relative Strength Index (RSI) is 53.5, which suggest Dyne Therapeutics is overbought
-
The Bollinger Bands (25) for Dyne Therapeutics is (10.52 - 12.2), which suggest Dyne Therapeutics is a Sell
-
The Bollinger Bands (100) for Dyne Therapeutics is (9.12 - 17.22), which suggest Dyne Therapeutics is a Sell
* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.